Research ArticleSpecial Contributions
Clinical Application of PET for the Evaluation of Brain Tumors
R. Edward Coleman, John M. Hoffman, Michael W. Hanson, H. Dirk Sostman and S. Clifford Schold
Journal of Nuclear Medicine April 1991, 32 (4) 616-622;
R. Edward Coleman
John M. Hoffman
Michael W. Hanson
H. Dirk Sostman


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Clinical Application of PET for the Evaluation of Brain Tumors
R. Edward Coleman, John M. Hoffman, Michael W. Hanson, H. Dirk Sostman, S. Clifford Schold
Journal of Nuclear Medicine Apr 1991, 32 (4) 616-622;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Apparent Diffusion Coefficient of Glial Neoplasms: Correlation with Fluorodeoxyglucose-Positron-Emission Tomography and Gadolinium-Enhanced MR Imaging
- [11C]-Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms
- Prognostic and Therapeutic Indicator of Fluoroboronophenylalanine Positron Emission Tomography in Patients with Gliomas
- 2-[18F]Fluoro-2-deoxyglucose and Glucose Uptake in Malignant Gliomas before and after Radiotherapy: Correlation with Outcome
- PET in Differentiation of Recurrent Brain Tumor from Radiation Injury
- High Microvascular Blood Volume Is Associated with High Glucose Uptake and Tumor Angiogenesis in Human Gliomas
- Brain Fluorine-18 Fluorodeoxyglucose Imaging with Dual-Head Coincidence Gamma Camera:Comparison with Dedicated Ring-Detector PositronEmission Tomography
- Positron emission tomography and the central nervous system